Live feed
·
INSIDERFilingvia Quantisnow
Aclaris Therapeutics Inc. logo

Amendment: Chief Business Officer Loerop James covered exercise/tax liability with 15,980 shares, decreasing direct ownership by 13% to 102,773 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Aclaris Therapeutics Inc. logo
ACRS
Aclaris Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2015
Follow ACRSFull ACRS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRS (Aclaris Therapeutics Inc.) and more on Quantisnow.